Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE2355.7564.2 (+2.8 %)

PREV CLOSE ( ) 2291.55

OPEN PRICE ( ) 2359.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8620

TODAY'S LOW / HIGH ( )2340.00 2405.00

52 WK LOW / HIGH ( )1275.05 2649.95

NSE2359.5572.55 (+3.17 %)

PREV CLOSE( ) 2287.00

OPEN PRICE ( ) 2385.00

BID PRICE (QTY) 2359.55 (749)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 126099

TODAY'S LOW / HIGH( ) 2342.00 2401.35

52 WK LOW / HIGH ( )1277.1 2524

Chairman	R S Karnad
Managing Director	Bhushan Akshikar
Company Secretary	Ajay Nadkarni
Executive Director	Juby Chandy
Non Executive Director	S Williams
Non Executive Independent Director	PV Bhide S Maheshwari A N Roy D Sundaram Manu Anand

Incorporation Year : 13-11 1924

Registered Office :

Address : Gsk House, Dr. Annie Besant Road,Worli, Mumbai,
Maharashtra-400030 .

Phone : 022-24959595

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX